Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease

We report a child with Coats disease who demonstrated a rapid response to intravitreal bevacizumab and triamcinolone injection. A 14-year-old boy presented with stage 3A Coats disease unresponsive to initial argon laser treatment and was injected with intravitreal bevacizumab and triamcinolone acetonide. Following intravitreal injection, a superior bullous exudative retinal detachment and subfoveal serous fluid collection dramatically improved. Additional argon laser photocoagulation resulted in complete regression of telangiectatic vessels as well as decrease in macular exudation. Visual acuity improved from 20/400 to 20/125 after treatment, and the boy remained stable 6 months after injection.